Recent News
Discovery Life Sciences Acquires AllCells
July 12, 2022
Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells® , a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than ...
Read More

SpecimenSeq Cancer Tissue Samples with Known Mutations
Thousands of tissue samples with full genotyping data make cohort selection a breeze. SpecimenSeq: Saving time, reducing cost, and accelerating research
July 6, 2022
Read MoreHansonwade Webinar | Next Generation Cell Therapies: Combined Analytics & Cryopreserved Starting Materials
June 28, 2022
CGT Industry experts and influencers Dr. Dominic Clarke, Daniel Ciccone, and Philip Eckels speak during a webinar to engage with these experts and gain valuable insights on process development strategies to improve ...
Read More
